These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1963029)

  • 1. Detection of 12-o-tetradecanoylphorbol-13-acetate-induced cellular proteins that compete with the Epstein-Barr virus nuclear antigen 1 (EBNA-1) for binding to a site within the Epstein-Barr virus oriP.
    Nonoyama M; Wen LT; Tanaka A; Bradley G
    Adv Exp Med Biol; 1990; 278():125-36. PubMed ID: 1963029
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells.
    Wen LT; Tanaka A; Nonoyama M
    J Virol; 1989 Aug; 63(8):3315-22. PubMed ID: 2545906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
    Allday MJ; MacGillivray AJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.
    Jones CH; Hayward SD; Rawlins DR
    J Virol; 1989 Jan; 63(1):101-10. PubMed ID: 2535719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological effects of EBNA 1 on oriP.
    Orlowski R; Miller G
    Adv Exp Med Biol; 1990; 278():115-24. PubMed ID: 1963028
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins.
    Wen LT; Lai PK; Bradley G; Tanaka A; Nonoyama M
    Virology; 1990 Sep; 178(1):293-6. PubMed ID: 2167556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1.
    Su W; Middleton T; Sugden B; Echols H
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10870-4. PubMed ID: 1660153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
    Inoue N; Harada S; Honma T; Kitamura T; Yanagi K
    Virology; 1991 May; 182(1):84-93. PubMed ID: 1850915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus.
    Frappier L; O'Donnell M
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10875-9. PubMed ID: 1660154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication.
    Hearing J; Mülhaupt Y; Harper S
    J Virol; 1992 Feb; 66(2):694-705. PubMed ID: 1309908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Ling PD; Rawlins DR; Hayward SD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution footprints of the DNA-binding domain of Epstein-Barr virus nuclear antigen 1.
    Kimball AS; Milman G; Tullius TD
    Mol Cell Biol; 1989 Jun; 9(6):2738-42. PubMed ID: 2548088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.
    Platt TH; Tcherepanova IY; Schildkraut CL
    J Virol; 1993 Mar; 67(3):1739-45. PubMed ID: 8382320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron microscopy of binding of Epstein-Barr virus (EBV) nuclear antigen (EBNA-1) to EBV DNA.
    Reischig J; Bartsch D; Polack A; Vonka V; Hirsch I
    Virology; 1987 Oct; 160(2):498-501. PubMed ID: 2821690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
    Gergely L; Luka J; Klein G
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.